29.07.2021 22:49:56

Edwards Lifesciences Corp. Q2 adjusted earnings Beat Estimates

(RTTNews) - Below are the earnings highlights for Edwards Lifesciences Corp. (EW):

-Earnings: $489.5 million in Q2 vs. -$121.9 million in the same period last year. -EPS: $0.78 in Q2 vs. -$0.20 in the same period last year. -Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $400.2 million or $0.64 per share for the period. -Analysts projected $0.55 per share -Revenue: $1.38 billion in Q2 vs. $0.92 billion in the same period last year.

-Guidance: Next quarter EPS guidance: $0.50 to $0.56 Next quarter revenue guidance: $1.29 to $1.37 Bln Full year revenue guidance: $5.2 to $5.4 Bln

Analysen zu Edwards Lifesciences Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Edwards Lifesciences Corp. 71,90 1,05% Edwards Lifesciences Corp.